Introduction
In addition to a still controversial role of renal Prostaglandins (PG) in the regulation of renal sodium excretion [ 11, accumulating evidence suggests that the renal PG system participates in the regulation of renal water excretion. High prostaglandin synthase activity is present in the renal medulla [2] and can be located in the renomedullary interstitial cells 13-51 and the collecting duct epithelium [6, 71. Studies in vitro in the toad urinary bladder I81 and the isolated collecting duct [9] have demonstrated that prostaglandin E (PGE) inhibits vasopressin-induced generation of adenosine 3' : 5'-cyclic monophosphate (cyclic AMP) by inhibiting vaso-pressin-activated adenyl cyclase. In addition, studies in vivo in acutely hypophysectomized dogs have shown that the renal concentrating response to exogenous arginine vasopressin ([Arg8]vasopressin) was markedly enhanced when the dogs were pretreated with the prostaglandin synthesis inhibitor, indomethacin [ 
101.
Further, studies in vitro in rabbit renomedullary interstitial cell cultures [51 and the toad urinary bladder [ 1 1 ] have demonstrated that [ArgE] vasopressin itself is a stimulator of PGE biosynthesis in these tissues. Thus the concept of a short-loop feedback between [Arg8]vasopressin and renal PG has been proposed in which [Arg*Ivasopressirr-itself stimulates synthesis of its antagonist prostaglandin E, (PGE,) in the collectingduct epithelial cells 111, 121. This idea has received further support by the finding that rats of the Brattleboro strain with g e e c central diabetes insipidus excrete minimal amounts of PGE, in their urine which can be significantly increased when polyuria is normalized by treatment with [Arg81vasopressin or the [Arg*Ivasopressin-analague I-desamino-8-arginine vasopressin (desamino-[Arg81vasopressin) . The present studies were therefore designed to investigate the renal PG system in healthy volunteer subjects during normal and excessive fluid intake and in patients with central diabetes insipidus before and during treatment with desamino-[Arg8]vasopressin without and with concomitant PG synthesis inhibition with indomethacin.
Methods
Studies were performed in six healthy volunteer subjects (four females and two males, aged 21-3 1 years) on a constant intake of 150 mmol of sodiumlday and 80 mmol of potassiumlday during normal and excessive fluid intake. They were first studied on a control day of fluid intake ad libitum and again when fluid intake was markedly raised by drinking approximately 1 litre of water every 4 h (10.00, 14.00, 18.00, 22 .00, 02.00, 06.00, 10.00 hours). Urine was collected for 24 h from 12.00 to 12.00 hours on the control day and during water loading.
In addition, five patients with diabetes insipidus (two females and three males, aged 17-48 years), one with idiopathic central diabetes insipidus and four members of one family with hereditary central diabetes insipidus were admitted to the study. In all patients, central diabetes insipidus was proven by the water-deprivation test [ 161. Except for one patient, in whom radiological evidence of bilateral ureteral obstruction was present, all patients revealed normal findings on physical examination, routine laboratory tests, chest film and intravenous pyelogram. The patients were hospitalized and equilibrated on a diet which contained 150 mmol of sodium and 80 mmol of potassium/day. Except for the patient who was diagnosed tp have idiopathic central diabetes insipidus shortly before the study, all patients had previously been treated with desamino-[Arg8 ]vasopressin. A11 medication had been discontinued at least 5 days before admission so that studies were performed in patients who had been polyuric for at least 4 days. The experimental protocol consisted of a control period of 1 day which was followed by 3 days of desamino-[Arg81vasopressin treatment, 7 5 pg every 12 h intranasally (12.00 hours and midnight). On day 3 of desamino-[Arg8]vasopressin treatment all patients received indomethacin (50 mg, orally at 12.00, 20.00 and 06.00 hours). Twenty-four hour urines were collected daily from 12.00 to 12.00 hours.
Urines were analysed for sodium, potassium, osmolality, creatinine, cyclic AMP and PGE,. Blood for determination of serum sodium and potassium concentrations, creatinine, plasma osmolality, plasma renin activity (PRA), plasma aldosterone and [Arg81vasopressin concentrations was drawn at 08.00 hours with subjects supine and again for PRA and plasma aldosterone at 11.00 hours after they had been ambulatory for 3 h (upright). Plasma and urine concentrations of sodium, potassium and creatinine were determined by flame photometry and a conventional autoanalyser method respectively. Plasma and urinary osmolalities were determined by freezing-point depression (Knauer osmometer). Glomerular filtration rate (GFR) was estimated as clearance of endogenous creatinine and osmolar (Cos,,) and free water clearances (CH2J were calculated according to conventional clearance formulae.
PRA was measured by-radioimmunoassay of angiotensin I (ANG I) [ 171. Results are expressed as pmol of ANG I generated h-' ml-' of plasma. One EU is defined as that amount of enzyme which catalyses the hydrolysis of 1 pmol of substrate per minute under the conditions of the assay (pH 8.2, 37OC). Urinary excretion of PGE, was measured by radioimmunoassay as described previously [22] . Volunteer subjects and patients had been informed before the study that sexual activity would interfere with PG measurements in their urine. In brief, samples of volumeadjusted urine were extracted twice with ethyl acetate. For volume adjustment, 24-h polyuric urine collections from both normal volunteer subjects during polydipsia and from untreated patients with diabetes insipidus were evaporated to volumes equalling those during control periods and during desamino-[Argslvasopressin treatment respectively. This procedure was not associated with losses of PGE,. The combined extracts were dried down under a stream of nitrogen and PGE, was separated from other PG and PG metabolites by silicic acid column chromatography. Radioimmunoassay of PGE, was performed with a highly specific rabbit antibody against PGE, (Institut Pasteur. Paris, France).
[3H]PGE, (New England Nuclear) was purified by column chromatography before use as a recovery tracer and in the assay. Unlabelled PGE, was kindly provided by Dr J. E. Pike, Upjohn Co., Kalamazoo, MI, U S A .
All assays were performed in duplicate. Results were corrected for recoveries and expressed as pmo1/24 h. Data are given as means f SEM. Statistical analysis of the data was performed by Student's paired t-test 1231.
Results

Changes in renal function
In normal volunteer subjects polydipsic water loading resulted in an increase in mean urine volume from 1203 f 242 (SEM) to 5072 f 320 m1/24 h (P < 0.001) with a decrease in urinary osmolality from 659 f 79 to 170 f. 19 mmol/kg (P < 0.001) and an increase in CHIO from -1.03 f 0 . 2 1 to 1.39fO-27 ml/min ( P < 0.001). These changes were associated with a decrease in plasma osmolality from 288 f 3 to 280 f 2 mmol/kg ( P < 0.025) and serum sodium concentration from 147 f 2 to 140 C 3 mmolll (P < 0.05). Water loading had no effect on GFR (134 f 6 vs 135 f 6 ml/min) or urinary excretion of sodium and potassium (Table 1) .
In patients with diabetes insipidus mean control urine volume was 10 838 f 107 m1/24 h and significantly decreased by day 2 of desamino- Significance of differences from control: * P < 0.001; ** P < 0,025; *** P < 0.05. mmol/l ( P < 0.002) and further decreased CHlo to -0.93 f 0.14 ml/min ( P < 0.05) without changes in GFR or urinary excretion of sodium and potassium (Fig. 1). (P < 0.05).
Plasma renin activity and plasma aldosterone and arginine vasopressin concentrations
In normal volunteer subjects supine and upright PRA measured 0.25 f 0.07 and 0.48 f 0.07 pmol h-' ml-' respectively, during the control day without a significant effect of water loading (0.27 f. 0.05 supine and 0.65 & 0.18 pmol h-' ml-' upright). In addition, no effect of polydipsia could be observed on (Table 1) . In patients with central diabetes insipidus plasma [Arg81vasopressin concentration was smaller than 0.2 fmol/ml in each of the five patients studied and therefore indistinguishable from zero in the [Arg81vasopressin radioimmunoassay system used. In these patients control supine PRA measured 0.08 f 0.04 pmol h-' m1-I and increased to 0.24 f. 0.06 pmol h-' ml-I with upright posture. Control PRA in the patient who had developed idiopathic central diabetes insipidus approximately 2 months before admission, and who had never been treated for this disorder, also revealed suppressed PRA with 0.04 supine and 0.20 pmol h-I ml-I upright. Desamino-[Args]vasopressin treatment slightly but not significantly decreased upright PRA to 0.06 k 0.02 pmol h-I ml-' and had no effect on supine PRA (0.05 f 0.01 pmol h-' ml-I). With concomitant indomethacin administration mean supine PRA was less than 0.04 pmol h-' ml-l, whereas upright PRA averaged 0.05 f. 
Urinary excretion of PGE,, cyclic AMP and kallikrein
In normal volunteer subjects on a free fluid intake urinary excretion of PGE, was 466 k 66 pmo1/24 h and slightly increased to 1017 k 174 pmo1/24 h (P = 0.05) during polydipsic water loading. Urinary excretion of kallikrein averaged 1.056 f 0.210 EU/24 h during the control day and was unchanged by polydipsia-induced polyuria (1.043 f. 0.237 EU/24 h). PGE, excretion was high in the patient who showed radiological evidence of bilateral ureteral obstruction (> 2500 pmo1/24 h). However, in the four untreated patients with uncomplicated central diabetes insipidus urinary excretion of PGE, averaged 246 k 66 pmo1/24 h and was significantly (P < 0.05) suppressed compared with urinary PGE, excretion in the normal volunteer subjects. In these patients treatment with desamino-[Arg81vasopressin raised urinary PGE, excretion to 2643 f 677 pmo1/24 h ( P < 0.01).
Concomitant indomethacin treatment subsequently suppressed urinary PGE, excretion to 909 k 251 pmo1/24 h (P < 0.01) compared with desamino-[Args]vasopressin treatment alone (Fig. 2) .
In (Fig. 1) .
In untreated patients with central diabetes insipidus urinary excretion of kallikrein was within the normal range and measured 1.160 & 0*090EU/24 h.
Discussion
The role of [Argslvasopressin in the regulation of renal PG production in uiuo is still controversial.
In contrast with studies which reported decreased urinary PG excretion in the absence of [ Arg*]vasopressin in polyuric rats with hereditary central diabetes insipidus [13-151 a close correlation between increased urinary PG excretion and high urine volume has been described in healthy volunteer subjects during polydipsic water loading [24] , in two patients with either nephrogenic or central diabetes insipidus 1251 and in dogs during water diuresis [26, 271 . These results suggest that urine volume itself might be an important determinant of urinary PGE excretion. However, in these studies, PG measurements were performed by radioimmunoassay and receptor assay respectively, with control values of urinary PGE excretion exceeding those obtained by gas chromatography/mass spectrometry [281.
Therefore, in the present study, samples of volume-adjusted urine (see the Methods section) were assayed for PGE, to avoid artificial increases in urinary PGE, excretion calculated for excessive urine volumes, which may be due to methodological problems inherent in PG receptor and immunological assay methods respectively [291. By this method we can show that in healthy volunteer subjects urinary excretion of PGE, only slightly increases with polydipsia-induced polyuria and that PGE, excretion is suppressed in patients with central diabetes insipidus despite their maximal water diuresis.
Studies [34] , in the present study no further increase in urinary cyclic AMP excretion after indomethacin could be observed in patients with central diabetes insipidus despite a significant increase in urine concentration. These results are in agreement with previous studies 135, 361 and may be explained as lack of urinary cyclic AMP properly to reflect intrarenal cfclic AMP production, especially that located in the collecting duct epithelium. On the other hand, they may also point to other mechanisms by which indomethacin might affect renal concentrating ability such as enhanced sodium chloride absorption in the ascending limb of Henle [37, 381 and/or decreased medullary washout of solute, both resulting in an increase in medullary tonicity 1391.
In conclusion, our results show that polyuria induced in normal subjects by polydipsic water loading is associated with a slight increase in urinary PGE, excretion which is of borderline statistical significance. In addition, urinary excretion of PGE, is markedly suppressed in patients with central diabetes insipidus and is significantly stimulated when urine volume is normalized by treatment with the [Argslvasopressin analogue desamino-[Args]vasopressin. PG synthesis inhibition significantly enhances the urinary concentrating response to desamino-[Args]vasopressin in these patients. This effect of PG inhibition is not associated with changes in urinary cyclic AMP excretion. Therefore, the desamino-[Args]-vasopressin antagonistic effect of renal PG may not solely involve inhibition of desamino-[ Args]-vasopressin-activated adenyl cyclase, but may also be due to altered intrarenal haemodynamics and/or changes in ascending loop reabsorptive capacity.
